HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement Firm Fails GMP Inspection Four Months After Third-Party Certification

Executive Summary

GMP warning to Nutra Solutions USA reflects not only that manufacturers and other supplement firms are responsible to maintain compliance at their facilities, but also third-party inspectors should be responsible for their certifications, say industry stakeholders.

You may also be interested in...



US FDA Targets Expanding Conduit For Supplement GMP Compliance Information

Gathering GMP information can be as problematic for agency as keeping tabs on all supplements available to US consumers. “Just to be clear, FDA believes we have a data gap in understanding the extent of the dietary supplements in the marketplace,” says ODSP Director Cara Welch.

Third-Party Assistance On US FDA’s Plate For Cutting Backlog Of Supplement Facility Inspections

“We had a good chunk of time when our investigators were not able to go out and get into facilities in a safe manner,” says Cara Welch, acting director of FDA Office of Dietary Supplement Programs. “I absolutely agree on starting the conversation for third-party inspections,” she adds.

NSF International Launches Hemp/CBD Testing Services

The Ann Arbor, MI-based testing and certification organization currently can analyze hemp-derived products for 12 cannabinoids, including THC, THCA, CBD and CBG, as well as impurities and harmful microbes, and certify offerings to USDA organic standards, among other services announced 18 September. NSF Director of Applied Research Jesse Miller discusses.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149240

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel